Tsubota Laboratory Faces Financial Strain Amid Rising Costs and Stock Downgrade

Tsubota Laboratory, Inc., a microcap company in the miscellaneous industry, has recently undergone an evaluation adjustment that reflects notable shifts in its financial landscape. The stock's score has transitioned from 'Not Rated' to 'Strong Sell,' indicating a significant revision in its evaluation metrics. The company has reported a challenging quarter ending in June 2025, marked by a decline in net sales, which reached JPY 24.85 million, and an operating profit of JPY -212.08 million. Additionally, raw material costs have surged by 38.2% year-over-year, contributing to the financial strain. Technical indicators present a mixed picture, with the MACD showing mildly bullish trends on both weekly and monthly bases, while the Bollinger Bands and moving averages indicate bearish conditions. The stock has also faced consistent underperformance against the Japan Nikkei 225 over the past three years, with a return of -18.40% in the last year, despite a significant rise in profits of 132.1%. These developments highlight the complexities surrounding Tsubota Laboratory, Inc.'s market position and performance indicators. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.